221 related articles for article (PubMed ID: 30809375)
21. The Usefulness of Ultrasonography for Supporting the Differentiation, Diagnosis, and Treatment of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma.
Crisan D; Schneider LA; Scharffetter-Kochanek K; Bernhard L; Crisan M; Wortsman X
J Ultrasound Med; 2024 May; ():. PubMed ID: 38703399
[TBL] [Abstract][Full Text] [Related]
22. Atypical fibroxanthoma and pleomorphic dermal sarcoma: Local recurrence and metastasis in a nationwide population-based cohort of 1118 patients.
Ørholt M; Abebe K; Rasmussen LE; Aaberg FL; Lindskov LJ; Schmidt G; Wagenblast AL; Petersen MM; Loya AC; Daugaard S; Herly M; Jensen DH; Vester-Glowinski P
J Am Acad Dermatol; 2023 Dec; 89(6):1177-1184. PubMed ID: 37634740
[TBL] [Abstract][Full Text] [Related]
23. Oncological Safety and Recurrence in the Surgical Treatment of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma of the Scalp.
Zeller J; Kiefer J; Braig D; Winninger O; Kraus D; Hagelstein S; Eisenhardt SU
Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740535
[TBL] [Abstract][Full Text] [Related]
24. Atypical fibroxanthoma/pleomorphic dermal sarcoma of the scalp with aberrant expression of HMB-45: a pitfall in dermatopathology.
Piras V; Ferreli C; Atzori L; Pinna G; Pilloni L
Pathologica; 2020 Jun; 112(2):105-109. PubMed ID: 32760054
[TBL] [Abstract][Full Text] [Related]
25. PRAME expression in spindle cell melanoma, malignant peripheral nerve sheath tumour, and other cutaneous sarcomatoid neoplasms: a comparative analysis.
Hrycaj SM; Szczepanski JM; Zhao L; Siddiqui J; Thomas DG; Lucas DR; Patel RM; Harms PW; Bresler SC; Chan MP
Histopathology; 2022 Dec; 81(6):818-825. PubMed ID: 36102613
[TBL] [Abstract][Full Text] [Related]
26. LN2, CD10, and Ezrin Do Not Distinguish Between Atypical Fibroxanthoma and Undifferentiated Pleomorphic Sarcoma or Predict Clinical Outcome.
Hanlon A; Stasko T; Christiansen D; Cyrus N; Galan A
Dermatol Surg; 2017 Mar; 43(3):431-436. PubMed ID: 28079637
[TBL] [Abstract][Full Text] [Related]
27. TERT promoter mutations are frequent in atypical fibroxanthomas and pleomorphic dermal sarcomas.
Griewank KG; Schilling B; Murali R; Bielefeld N; Schwamborn M; Sucker A; Zimmer L; Hillen U; Schaller J; Brenn T; Schadendorf D; Mentzel T
Mod Pathol; 2014 Apr; 27(4):502-8. PubMed ID: 24030750
[TBL] [Abstract][Full Text] [Related]
28. Clear cell variant of atypical fibroxanthoma and pleomorphic dermal sarcoma: Molecular characterization and review of the literature.
Coelho-Lima J; Bruty J; Watkins J; Liu H; Price R; Stefanos N
J Cutan Pathol; 2022 Dec; 49(12):1031-1034. PubMed ID: 35922373
[TBL] [Abstract][Full Text] [Related]
29. Proteomic analysis of pleomorphic dermal sarcoma reveals a fibroblastic cell of origin and distinct immune evasion mechanisms.
Klein S; Tolkach Y; Reinhardt HC; Buettner R; Quaas A; Helbig D
Sci Rep; 2024 May; 14(1):12516. PubMed ID: 38822058
[TBL] [Abstract][Full Text] [Related]
30. Pleomorphic dermal sarcoma: Clinicopathological features and outcomes from a 5-year tertiary referral centre experience.
Logan IT; Vroobel KM; le Grange F; Perrett CM
Cancer Rep (Hoboken); 2022 Nov; 5(11):e1583. PubMed ID: 34766474
[TBL] [Abstract][Full Text] [Related]
31. Pleomorphic Dermal Sarcoma of the Scalp.
Klebanov N; Hoang MP; Reddy BY
Cureus; 2018 Jul; 10(7):e2979. PubMed ID: 30237940
[TBL] [Abstract][Full Text] [Related]
32. Expression of proton-sensing G-protein-coupled receptors in selected skin tumors.
Nassios A; Wallner S; Haferkamp S; Klingelhöffer C; Brochhausen C; Schreml S
Exp Dermatol; 2019 Jan; 28(1):66-71. PubMed ID: 30339292
[TBL] [Abstract][Full Text] [Related]
33. Fine needle aspiration cytopathology of pleomorphic dermal sarcoma.
Challa BS; Plaza JA; Wakely PE
Cytopathology; 2023 Sep; 34(5):472-478. PubMed ID: 37204069
[TBL] [Abstract][Full Text] [Related]
34. TERT promoter hotspot mutations are recurrent in myxoid liposarcomas but rare in other soft tissue sarcoma entities.
Koelsche C; Renner M; Hartmann W; Brandt R; Lehner B; Waldburger N; Alldinger I; Schmitt T; Egerer G; Penzel R; Wardelmann E; Schirmacher P; von Deimling A; Mechtersheimer G
J Exp Clin Cancer Res; 2014 Apr; 33(1):33. PubMed ID: 24726063
[TBL] [Abstract][Full Text] [Related]
35. Pleomorphic dermal sarcoma: it might be rare but it exists.
Seretis K; Klaroudas A; Galani V; Papathanakos G; Varouktsi A; Mitselou A; Batistatou A; Lampri E
J Surg Case Rep; 2023 Aug; 2023(8):rjad374. PubMed ID: 37545789
[TBL] [Abstract][Full Text] [Related]
36. Atypical Fibroxanthoma Treated with a Topical Combination of Imiquimod, Tazarotene, and 5-Fluorouracil.
Nahm WJ; Badiavas EV; Kirsner RS; Boyd CJ; Arthur AA; Bae S; Shen J
Dermatol Ther (Heidelb); 2024 Apr; 14(4):1049-1056. PubMed ID: 38467988
[TBL] [Abstract][Full Text] [Related]
37. Intimal sarcomas and undifferentiated cardiac sarcomas carry mutually exclusive MDM2, MDM4, and CDK6 amplifications and share a common DNA methylation signature.
Koelsche C; Benhamida JK; Kommoss FKF; Stichel D; Jones DTW; Pfister SM; Heilig CE; Fröhling S; Stenzinger A; Buslei R; Mentzel T; Baumhoer D; Ladanyi M; Antonescu CR; Flucke U; Gorp JV; Bode-Lesniewska B; Deimling AV; Mechtersheimer G
Mod Pathol; 2021 Dec; 34(12):2122-2129. PubMed ID: 34312479
[TBL] [Abstract][Full Text] [Related]
38. Sarcoma-like tumor of head and neck skin.
Nonaka D; Bishop PW
Am J Surg Pathol; 2014 Jul; 38(7):956-65. PubMed ID: 24705313
[TBL] [Abstract][Full Text] [Related]
39. A Multidisciplinary Approach to Complex Dermal Sarcomas Ensures an Optimal Clinical Outcome.
Trøstrup H; Bigdeli AK; Krogerus C; Kneser U; Schmidt G; Schmidt VJ
Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406465
[TBL] [Abstract][Full Text] [Related]
40. Microphthalmia transcription factor and melanoma cell adhesion molecule expression distinguish desmoplastic/spindle cell melanoma from morphologic mimics.
Koch MB; Shih IM; Weiss SW; Folpe AL
Am J Surg Pathol; 2001 Jan; 25(1):58-64. PubMed ID: 11145252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]